Package 67877-614-15

{"route": ["ORAL"], "spl_id": "e9f19258-b62c-471d-82c4-1e2bdc030833", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["72f25135-1333-4e52-83f5-7df7d90e68bb"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (67877-614-05)", "package_ndc": "67877-614-05", "marketing_start_date": "20190127"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (67877-614-15)", "package_ndc": "67877-614-15", "marketing_start_date": "20190127"}], "brand_name": "Tizanidine", "product_id": "67877-614_e9f19258-b62c-471d-82c4-1e2bdc030833", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "67877-614", "generic_name": "Tizanidine", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA211798", "marketing_category": "ANDA", "marketing_start_date": "20190127", "listing_expiration_date": "20261231"}